Trevena (NASDAQ:TRVN) Now Covered by StockNews.com
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report released on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “neutral” rating and set a $5.00 target price on shares of Trevena in a research note on Thursday, November 14th. View Our […]
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report released on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “neutral” rating and set a $5.00 target price on shares of Trevena in a research note on Thursday, November 14th. View Our […]
